• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

BMS eyes April FDA verdict on Opdivo/Yervoy in liver cancer

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 22, 2024 at 11:12: AM
via The FDA has started a review of Bristol-Myers Squibb's immunotherapy duo Opdivo and Yervoy as a therapy for newly diagnosed unresectable liver cancer that could see a return to the category for the drugmaker.

article source
 






Top Bottom
Back
Quote